Bryce P. Portier

Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics

Rashmi Kanagal‐Shamanna, Bryce P. Portier, Rajesh R. Singh et al. · Modern Pathology · 2013 · 211 citations

Routine Clinical Diagnostics, Oncology, Somatic Variant +9

Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells

Warren Fiskus, Sunil Sharma, Jun Qi et al. · Molecular Cancer Therapeutics · 2014 · 189 citations

Histone Modifications, Histone Deacetylase Inhibitor, Family Members +16

BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD

Warren Fiskus, Sunil Sharma, Jun Qi et al. · Molecular Cancer Therapeutics · 2014 · 137 citations · Full text

A Transcript Map of the Chromosome 19q-Arm Glioma Tumor Suppressor Region

Justin S. Smith, Issei Tachibana, Ute Pohl et al. · Genomics · 2000 · 125 citations

Chromatin, Tumor Heterogeneity, Medicine +9

ALK Status Testing in Non–Small Cell Lung Carcinoma

Eugen C. Minca, Bryce P. Portier, Zhen Wang et al. · Journal of Molecular Diagnostics · 2013 · 121 citations · Full text